New Agents for the Management of Tenosynovial Giant Cell Tumor: A Virtual Reality Tour of CSF1 Pathway Inhibitors

This enduring activity is focused on the management of patients with tenosynovial giant cell tumor (TGCT).

Release Date: November 18, 2020
Expiration Date: November 18, 2021